Saikogenin DCAS# 5573-16-0 |
- Saikogenin A
Catalog No.:BCX1580
CAS No.:5092-09-1
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 5573-16-0 | SDF | Download SDF |
| PubChem ID | 9890994 | Appearance | Powder |
| Formula | C30H48O4 | M.Wt | 472.71 |
| Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (3S,4R,4aR,6aR,6bS,8R,8aS,14aR,14bS)-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,14a-dodecahydropicene-3,8-diol | ||
| SMILES | CC1(CCC2(C(CC3(C(=C2C1)C=CC4C3(CCC5C4(CCC(C5(C)CO)O)C)C)C)O)CO)C | ||
| Standard InChIKey | QGNVMEXLLPGQEV-IULQVHCXSA-N | ||
| Standard InChI | InChI=1S/C30H48O4/c1-25(2)13-14-30(18-32)20(15-25)19-7-8-22-26(3)11-10-23(33)27(4,17-31)21(26)9-12-28(22,5)29(19,6)16-24(30)34/h7-8,21-24,31-34H,9-18H2,1-6H3/t21-,22-,23+,24-,26+,27+,28-,29-,30-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Saikogenin D possesses a dual effect: an inhibition of A23187-induced PGE2 production without a direct inhibition of cyclooxygenase activity; and an elevation of [Ca2+]i that is attributed to Ca2+ release from intracellular stores. 2. Saikogenin D has immunomodulatory effect, it can attenuate IL-6 production in LPS-stimulated alveolar macrophages of B6 more than in that of BALB. |
| Targets | PGE | Calcium Channel | IL Receptor |
Saikogenin D Dilution Calculator
Saikogenin D Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.1155 mL | 10.5773 mL | 21.1546 mL | 42.3092 mL | 52.8865 mL |
| 5 mM | 0.4231 mL | 2.1155 mL | 4.2309 mL | 8.4618 mL | 10.5773 mL |
| 10 mM | 0.2115 mL | 1.0577 mL | 2.1155 mL | 4.2309 mL | 5.2887 mL |
| 50 mM | 0.0423 mL | 0.2115 mL | 0.4231 mL | 0.8462 mL | 1.0577 mL |
| 100 mM | 0.0212 mL | 0.1058 mL | 0.2115 mL | 0.4231 mL | 0.5289 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Vinaginsenoside R8
Catalog No.:BCN8567
CAS No.:156042-22-7
- 3-Feruloyl-1-Sinapoyl sucrose
Catalog No.:BCN8566
CAS No.:98942-06-4
- Periplocoside N
Catalog No.:BCN8565
CAS No.:39946-41-3
- Lancifodilactone F
Catalog No.:BCN8564
CAS No.:850878-47-6
- 3'-Demethylnobiletin
Catalog No.:BCN8563
CAS No.:112448-39-2
- Erigoster B
Catalog No.:BCN8562
CAS No.:849777-61-3
- Acanthopanaxoside B
Catalog No.:BCN8561
CAS No.:915792-03-9
- Glabrolide
Catalog No.:BCN8560
CAS No.:10401-33-9
- Anemarrhenasaponin I
Catalog No.:BCN8559
CAS No.:163047-21-0
- Dihydropalmatine
Catalog No.:BCN8558
CAS No.:26067-60-7
- Rupestonic acid
Catalog No.:BCN8557
CAS No.:115473-63-7
- Uvarigranol B
Catalog No.:BCN8556
CAS No.:164204-79-9
- Gancaonin N
Catalog No.:BCN8569
CAS No.:129145-52-4
- Graveobioside A
Catalog No.:BCN8570
CAS No.:506410-53-3
- 2-Amino-3-carboxy-1,4-naphthoquinone
Catalog No.:BCN8571
CAS No.:173043-38-4
- 4'-O-Methylochnaflavone
Catalog No.:BCN8572
CAS No.:49619-87-6
- Perisesaccharide B
Catalog No.:BCN8573
CAS No.:1095261-93-0
- Tectol
Catalog No.:BCN8574
CAS No.:24449-39-6
- Jionoside D
Catalog No.:BCN8575
CAS No.:120406-34-0
- 5,6-Dehydroginsenoside Rd
Catalog No.:BCN8576
CAS No.:1268459-68-2
- Epitheaflagallin 3-O-gallate
Catalog No.:BCN8577
CAS No.:102067-92-5
- Hexamethylquercetagetin
Catalog No.:BCN8578
CAS No.:1251-84-9
- 4-Benzamido-2,5-diethoxybenzenediazonium
Catalog No.:BCN8579
CAS No.:5486-84-0
- Uvarigrin
Catalog No.:BCN8580
CAS No.:200563-11-7
Dual effect of saikogenin D: in vitro inhibition of prostaglandin E2 production and elevation of intracellular free Ca2+ concentration in C6 rat glioma cells.[Pubmed:14531029]
Planta Med. 2003 Aug;69(8):765-7.
To clarify the pharmacological profile of Saikogenin D, we examined the effect of Saikogenin D on prostaglandin E2 (PGE2) production and intracellular free Ca2+ concentration ([Ca2+]i) in C6 rat glioma cells. Saikogenin D (1-20 microM) inhibited PGE2 production induced by the Ca2+ ionophore A23187 in a concentration-dependent manner with the IC50 of about 3 microM. Saikogenin D did not affect the conversion of arachidonic acid into PGE2 in microsomal preparations. On the other hand, Saikogenin D elevated [Ca2+]i in a concentration-dependent manner (10-100 microM) with the EC50 value of about 35 microM in the presence or absence of extracellular Ca2+. These results suggest that Saikogenin D possesses a dual effect: an inhibition of A23187-induced PGE2 production without a direct inhibition of cyclooxygenase activity; and an elevation of [Ca2+]i that is attributed to Ca2+ release from intracellular stores.
The herbal medicine Shosaiko-to exerts different modulating effects on lung local immune responses among mouse strains.[Pubmed:11811938]
Int Immunopharmacol. 2002 Feb;2(2-3):357-66.
Shosaiko-to (SST), a Chinese/Japanese traditional herbal medicine, has recently been demonstrated to increase lung interleukin-6 (IL-6) levels and to ameliorate pulmonary disorders in BALB/c mice (BALB). In the present study, we examined the effects of SST on lung cytokine levels and lipopolysaccharide (LPS)-induced lung injury in C57BL/6 mice (B6), which are known to show different immune responses from BALB due to the difference in genetic backgrounds. In B6, in contrast with BALB, SST decreased lung IL-6 levels and exacerbated LPS-induced lung injury. Investigation of the active components of SST suggested that multiple ingredients were supposed to be responsible for IL-6-attenuating activity in vivo. Further, we examined the effect of metabolites of major ingredients of SST on IL-6 production from lung immune cells in vitro. Saikogenin D and oroxylin A attenuated IL-6 production in LPS-stimulated alveolar macrophages of B6 more than in that of BALB. Liquiritigenin, which was previously reported to enhance IL-6 production in anti-CD3 monoclonal antibody-stimulated lung mononuclear cells of BALB, showed no effect on that of B6. These findings suggest that SST may have different, possibly even opposite, effects on lung immunity in hosts with different genetic backgrounds.
